✦ LIBER ✦

Results in the elderly with locally advanced rectal cancer from the ACCOR12/PRODIGE 2 phase III trial: Tolerance and efficacy

✍ Scribed by François, Eric; Azria, David; Gourgou-Bourgade, Sophie; Jarlier, Marta; Martel-Laffay, Isabelle; Hennequin, Christophe; Etienne, Pierre-Luc; Vendrely, Véronique; Seitz, Jean-François; Conroy, Thierry; Juzyna, Beata; Gerard, Jean-Pierre

Book ID: 122224998
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 345 KB
Volume: 110
Category: Article
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2013.10.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Two Neoadjuvant Chemoradio

Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2

✍ Gerard, J.-P.; Azria, D.; Gourgou-Bourgade, S.; Martel-Laffay, I.; Hennequin, C. 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 116 KB

Comparison of the efficacy and tolerabil

Comparison of the efficacy and tolerability of ZD9331 with gemcitabine in locally advanced or metastatic pancreatic cancer: phase II/III trial

✍ Smith, D.; Gallagher, N. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

886 THE EFFICACY AND TOLERABILITY OF MIR

886 THE EFFICACY AND TOLERABILITY OF MIRABEGRON IN PATIENTS WITH OVERACTIVE BLADDER – RESULTS FROM A EUROPEAN–AUSTRALIAN PHASE III TRIAL

✍ V. Khullar; J. Cambronero; P. Ströberg; J. Angulo; P. Boerrigter; M.B. Blauwet; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

662 THE SURVIVAL BENEFIT OF PRIOR DEFINI

662 THE SURVIVAL BENEFIT OF PRIOR DEFINITIVE LOCAL THERAPY IN MEN WITH ADVANCED/METASTATIC PROSTATE CANCER: RESULTS FROM A PHASE III PROSPECTIVE RANDOMIZED TRIAL

✍ Williams, Michael; Millikan, Randall; Wang, Xuemei; Pettaway, Curtis 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 43 KB

Long-term results with immediate androge

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

✍ Michel Bolla; Laurence Collette; Léo Blank; Padraig Warde; Jean Bernard Dubois; 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 105 KB

Cyclophosphamide and liposomal-encapsula

Cyclophosphamide and liposomal-encapsulated doxorubicin (MYOCET®) in elderly women with HER-2 negative locally advanced or metastatic breast cancer: Preliminary results of a multicenter phase II trial from the Hellenic Oncology Research Group

✍ Karampeazis⁎, A.; Ardavanis, A.; Kentepozidis, N.; Nikolaou, Ch.; Bozionelou, V. 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 80 KB